Showing results (2471-2480 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|September 4, 2004
Cost effectiveness of cephalosporin monotherapy and aminoglycoside/ureidopenicillin combination therapy. For the treatment of febrile episodes in neutropenic patientsJ A Paladino, L D Fong, A Forrest, et al.Pharmacoeconomics|September 20, 2002
Information barriers to the implementation of economic evaluations in JapanShuzo Nishimura, George W Torrance, Naoki Ikegami, et al.Pharmacoeconomics|September 22, 2005
Discounting health effects in pharmacoeconomic evaluations: current controversiesJ M Bos, Maarten J Postma, Lieven AnnemansPharmacoeconomics|June 18, 2005
Pharmacoeconomic evaluation of antidepressants : a critical appraisal of methodsSheikh Usman Iqbal, Mark PrashkerPharmacoeconomics|May 18, 2005
Willingness to pay for a QALY: theoretical and methodological issuesDorte Gyrd-HansenPharmacoeconomics|April 20, 2005
International variation in resource utilisation and treatment costs for rheumatoid arthritis: a systematic literature reviewHubertus Rosery, Rito Bergemann, Stefanie Maxion-BergemannPharmacoeconomics|February 8, 2005
A review of the costs of managing childhood epilepsyEttore Beghi, Barbara Frigeni, Massimiliano Beghi, et al.Pharmacoeconomics|March 8, 2006
Quality-of-life valuations of advanced breast cancer by New Zealand womenRichard J Milne, Kathy H Heaton-Brown, Paul Hansen, et al.Pharmacoeconomics|August 11, 2006
Prostaglandin analogues for the treatment of glaucoma and ocular hypertension: a systematic review of economic evidenceMichelle Orme, Annabel BolerPharmacoeconomics|October 28, 2006
Analysis sans frontières: can we ever make economic evaluations generalisable across jurisdictions?Mark J Sculpher, Michael F DrummondPageof 336